| Health Systems, Economic Evaluations, Quality of Life | Lifetime | 84 | CA 9 | 99.64 |
| Cardiac, Anesthesia and Surgical Outcomes | Lifetime | 133 | CA 10 | 99.61 |
| Pharmaceutical Practices and Patient Outcomes | Lifetime | 34 | CA 5 | 99.34 |
| Blood Pressure and Hypertension Studies | Lifetime | 79 | CA 4 | 99.65 |
| Chronic Disease Management Strategies | Lifetime | 53 | CA 5 | 99.31 |
| Heart Failure Treatment and Management | Lifetime | 82 | CA 5 | 99.69 |
| COVID-19 and healthcare impacts | Lifetime | 82 | CA 2 | 98.20 |
| Emergency and Acute Care Studies | Lifetime | 93 | CA 17 | 99.16 |
| Clinical practice guidelines implementation | Lifetime | 57 | CA 11 | 99.03 |
| Health Sciences Research and Education | Lifetime | 36 | CA 15 | 98.86 |
| Medication Adherence and Compliance | Lifetime | 55 | CA 3 | 98.76 |
| Cardiac pacing and defibrillation studies | Lifetime | 369 | CA 23 | 98.86 |
| Diabetes Treatment and Management | Lifetime | 393 | CA 19 | 98.51 |
| Cardiovascular Function and Risk Factors | Lifetime | 924 | CA 41 | 98.47 |
| Sodium Intake and Health | Lifetime | 105 | CA 6 | 98.18 |
| Atrial Fibrillation Management and Outcomes | Lifetime | 831 | CA 70 | 98.10 |
| Primary Care and Health Outcomes | Lifetime | 421 | CA 31 | 97.66 |
| Healthcare Policy and Management | Lifetime | 543 | CA 31 | 97.44 |
| Acute Myocardial Infarction Research | Lifetime | 643 | CA 42 | 98.09 |
| Electrolyte and hormonal disorders | Lifetime | 324 | CA 15 | 96.93 |
| Meta-analysis and systematic reviews | Lifetime | 185 | CA 35 | 97.11 |
| Cardiac Health and Mental Health | Lifetime | 523 | CA 41 | 96.70 |
| Lipoproteins and Cardiovascular Health | Lifetime | 826 | CA 51 | 96.86 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 513 | CA 18 | 94.29 |
| Pharmaceutical industry and healthcare | Lifetime | 194 | CA 16 | 93.41 |
| Pharmaceutical Economics and Policy | Lifetime | 734 | CA 53 | 92.83 |
| Healthcare cost, quality, practices | Lifetime | 724 | CA 59 | 92.47 |
| Potassium and Related Disorders | Lifetime | 407 | CA 26 | 92.71 |
| Medical Coding and Health Information | Lifetime | 163 | CA 21 | 89.86 |
| Enhanced Recovery After Surgery | Lifetime | 609 | CA 48 | 90.79 |
| Health and Medical Research Impacts | Lifetime | 695 | CA 50 | 89.34 |
| Health Promotion and Cardiovascular Prevention | Lifetime | 944 | CA 53 | 85.12 |
| Hospital Admissions and Outcomes | Lifetime | 981 | CA 61 | 78.48 |
| Heart rate and cardiovascular health | Lifetime | 457 | CA 17 | 77.42 |
| Medical Research and Practices | Lifetime | 198 | CA 22 | 65.56 |
| COVID-19 and healthcare impacts | 2021-2025 | 167 | CA 6 | 96.51 |
| Blood Pressure and Hypertension Studies | 2021-2025 | 412 | CA 14 | 94.05 |
| Heart Failure Treatment and Management | 2021-2025 | 491 | CA 17 | 94.17 |
| Cardiovascular Syncope and Autonomic Disorders | 2021-2025 | 192 | CA 13 | 87.62 |
| Electrolyte and hormonal disorders | 2021-2025 | 671 | CA 28 | 66.50 |
